Cannabis Stocks Mostly Higher as Sector Braces for FDA Hearing on Rules for CBD

Hexo gains after naming a U.S. CFO, Acreage voices support for Canopy’s proposed deal ahead of shareholder vote. Cannabis stocks were mostly higher Tuesday, as investors braced for a Friday hearing by the U.S. Food and Drug Administration on how to regulate cannabis and its popular ingredient, CBD. CBD, a non-intoxicating substance, is widely held to have wellness properties, although not a lot of research has been conducted as yet, as MarketWatch’s Sarah Toy has…


Go to Source

Powered by WPeMatico